- Home
- NEGG vs STXS Comparison
NEGG vs STXS Comparison
Compare NEGG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- STXS
- Stock Information
- Founded
- NEGG 2001
- STXS 1990
- Country
- NEGG United States
- STXS United States
- Employees
- NEGG N/A
- STXS N/A
- Industry
- NEGG Other Specialty Stores
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NEGG Consumer Discretionary
- STXS Health Care
- Exchange
- NEGG Nasdaq
- STXS Nasdaq
- Market Cap
- NEGG 122.3M
- STXS 151.3M
- IPO Year
- NEGG 2010
- STXS 2004
- Fundamental
- Price
- NEGG $37.01
- STXS $2.28
- Analyst Decision
- NEGG
- STXS
- Analyst Count
- NEGG 0
- STXS 0
- Target Price
- NEGG N/A
- STXS N/A
- AVG Volume (30 Days)
- NEGG 715.8K
- STXS 288.7K
- Earning Date
- NEGG 08-28-2025
- STXS 08-11-2025
- Dividend Yield
- NEGG N/A
- STXS N/A
- EPS Growth
- NEGG N/A
- STXS N/A
- EPS
- NEGG N/A
- STXS N/A
- Revenue
- NEGG $1,235,576,000.00
- STXS $27,510,000.00
- Revenue This Year
- NEGG N/A
- STXS $25.90
- Revenue Next Year
- NEGG N/A
- STXS $60.57
- P/E Ratio
- NEGG N/A
- STXS N/A
- Revenue Growth
- NEGG N/A
- STXS 1.50
- 52 Week Low
- NEGG $3.32
- STXS $1.54
- 52 Week High
- NEGG $56.00
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- NEGG 72.22
- STXS 54.48
- Support Level
- NEGG $15.31
- STXS $2.12
- Resistance Level
- NEGG $56.00
- STXS $2.36
- Average True Range (ATR)
- NEGG 5.12
- STXS 0.09
- MACD
- NEGG 2.83
- STXS 0.00
- Stochastic Oscillator
- NEGG 62.24
- STXS 64.00
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.